Nucleotide mimics and their prodrugs

The present invention relates to nucleoside diphosphate mimics and nucleoside triphosphate mimics, which contain diphosphate or triphosphate moiety mimics and optionally sugar-modifications and/or base-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acc...

Full description

Saved in:
Bibliographic Details
Main Authors Cook, Phillip D, Wang, Guangyi, Bruice, Thomas W, Boyle, Nicholas A, Leeds, Janet M, Brooks, Jennifer L, Prhavc, Marija, Ariza, Maria Eugenia, Fagan, Patrick C, Jin, Yi, Rajwanshi, Vivek K, Tucker, Kathleen D
Format Patent
LanguageEnglish
Published 05.10.2010
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to nucleoside diphosphate mimics and nucleoside triphosphate mimics, which contain diphosphate or triphosphate moiety mimics and optionally sugar-modifications and/or base-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acceptable salt, a pharmaceutically acceptable prodrug, or a pharmaceutical formulation, are useful as antiviral, antimicrobial, and anticancer agents. The present invention provides a method for the treatment of viral infections, microbial infections, and proliferative disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of the present invention optionally in combination with other pharmaceutically active agents.